Medx Health Corp

TSXV:MDXCanadaView on OTC Pink - Current Information

May 1, 2024

Show headlines and story abstract

• MedX Announces Proposed Non-Brokered Private Placement to Raise up to $2,000,000 and Provides an Update on Amendment to Series I Convertible Notes, from 8:00AM ET on Wednesday May 01, 2024 by Business Wire

  8:00AM ET on Wednesday May 01, 2024 by Business Wire
  Companies Mentioned: MDXHF

  MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) is pleased to announce that it is proposing to raise up to $2,000,000 by way of a Non-Brokered Private Placement of up to 28,571,428 Units at $0.07 per Unit ("Unit"). A Price Reservation Form for this proposed placement was filed with the TSXV on April 19, 2024. Each Unit will be comprised of One (1) fully paid common share and One (1) Share Purchase Warrant, exercisable to purchase One (1) further Common Share at the price of $0.12, exercisable for a period commencing on the date of issue and expiring on December 31, 2026. Closing of the Placement, which may take place in tranches, will be subject to receipt of subscriptions for a minimum of $500,000 and a number of other conditions, including without limitation the receipt of all relevant regulatory and Stock Exchange approvals or acceptances. Qualified Agents may receive commissions in respect of subscriptions introduced by them by way of cash equal to 6% of funds so introduced. Warrants to be issued will have a "Call" feature, empowering the Company to Call the Warrants for exercise at any time while they are outstanding after January 1, 2026, if the average closing price of the Company's common shares on the market over a period of 20 trading days in any period of thirty consecutive trading days is at or above $0.24. The Call procedure provides that the Company may give Notice to Exercise within 30 days, after which date any unexercised Warrants will become void.

• MedX Announces Proposed Non-Brokered Private Placement to Raise up to $2,000,000 and Provides an Update on Amendment to Series I Convertible Notes, from 8:00AM ET on Wednesday May 01, 2024 by Dow Jones

  8:00AM ET on Wednesday May 01, 2024 by Dow Jones
  Companies Mentioned: MDX
  MISSISSAUGA, Ontario--(BUSINESS WIRE)--May 01, 2024--
  MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) is pleased to announce that it is proposing to raise up to $2,000,000 by way of a Non-Brokered Private Placement of up to 28,571,428 Units at $0.07 per Unit ("Unit"). A Price Reservation Form for this proposed placement was filed with the TSXV on April 19, 2024. Each Unit will be comprised of One (1) fully paid common share and One (1) Share Purchase Warrant, exercisable to purchase One (1) further Common Share at the price of $0.12, exercisable for a period commencing on the date of issue and expiring on December 31, 2026. Closing of the Placement, which may take place in tranches, will be subject to receipt of subscriptions for a minimum of $500,000 and a number of other conditions, including without limitation the receipt of all relevant regulatory and Stock Exchange approvals or acceptances. Qualified Agents may receive commissions in respect of subscriptions introduced by them by way of cash equal to 6% of funds so introduced. Warrants to be issued will have a "Call" feature, empowering the Company to Call the Warrants for exercise at any time while they are outstanding after January 1, 2026, if the average closing price of the Company's common shares on the market over a period of 20 trading days in any period of thirty consecutive trading days is at or above $0.24. The Call procedure provides that the Company may give Notice to Exercise within 30 days, after which date any unexercised Warrants will become void.